Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 56Neoplasms 20Pain 18Fatigue 11Peripheral Nervous System Diseases 10Lung Neoplasms 10Hot Flashes 10Prostatic Neoplasms 9Multiple Myeloma 9Polycystic Ovary Syndrome 7Sleep Initiation and Maintenance Disorders 6Anxiety Disorders 6Stomach Neoplasms 5Pancreatic Neoplasms 5Depression 5Colorectal Neoplasms 5Agnosia 5Lymphoma 4Lymphedema 4Insulin Resistance 4Head and Neck Neoplasms 4Cancer Pain 4Xerostomia 3Squamous Cell Carcinoma of Head and Neck 3Nasopharyngeal Neoplasms 3Lymphoma, Non-Hodgkin 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vomiting 2

Interventions

Gemcitabine 157Cisplatin 116pembrolizumab 80Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Cystectomy 40Docetaxel 38atezolizumab 33Magnetic Resonance Spectroscopy 31durvalumab 30Radiotherapy 29BCG Vaccine 26avelumab 24Specimen Handling 24Doxorubicin 23enfortumab vedotin 22Fluorouracil 20Cystoscopy 20Methotrexate 17Vinblastine 16Standard of Care 15Filgrastim 14Transurethral Resection of Bladder 13Sunitinib 13Ipilimumab 13vinflunine 125-aminolevulinic acid hexyl ester 12tremelimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Urinary Bladder Neoplasms × Acupuncture Therapy × Clear all
NCT07548476 2026-05-04

ACE

Dana-Farber Cancer Institute

Phase NA Not yet recruiting
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Peripheral Nervous System Diseases

NCT04496219 2024-01-02

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
45 enrolled 16 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡